Tarsus Pharmaceuticals, Inc. (TARS) ownership: Top institutional holder: Deep Track Capital, LP ($252.54M). Insider activity: Net Seller (0 buys, 20 sells). SEC EDGAR first-party data.
| Holder | Shares | Market Value | Reported |
|---|---|---|---|
| Deep Track Capital, LP | 3600000.00 | $252.54M | 2026-03-31 |
| BlackRock, Inc. | 3552612.00 | $249.22M | 2026-03-31 |
| RTW INVESTMENTS, LP | 3346025.00 | $234.72M | 2026-03-31 |
| VANGUARD GROUP INC | 2399560.00 | $196.48M | 2025-12-31 |
| Paradigm Biocapital Advisors LP | 2562154.00 | $179.74M | 2026-03-31 |
| Jupiter Topco LLC | 2808796.00 | $176.83M | 2026-06-30 |
| JANUS HENDERSON GROUP PLC | 2240963.00 | $157.22M | 2026-03-31 |
| MORGAN STANLEY | 1944272.00 | $136.39M | 2026-03-31 |
| Insider | Transaction | Value | Date |
|---|---|---|---|
| Sell | null | 2026-06-25 | |
| Sell | null | 2026-06-25 | |
| Sell | null | 2026-06-25 | |
| Sell | null | 2026-06-25 | |
| Sell | null | 2026-06-25 | |
| Sell | null | 2026-06-25 | |
| Sell | null | 2026-06-25 | |
| Sell | null | 2026-06-25 |
Back to TARS overview · TARS earnings · All congressional trades
Institutional data from SEC Form 13F. Insider data from SEC Form 4. Congressional data from STOCK Act disclosures. Not personalized investment advice.